Register for our free email digests:
Illumina Inc.
www.illumina.com
Latest From Illumina Inc.
Lift-Off For Lilly In Cancer Genetics With Loxo Buy
The New Year is just a week old but the biopharma merger and acquisitions merry-go-round is already spinning furiously as Lilly now steps in with a proposal to buy Loxo.
FDA Nod For Loxo/Bayer Tissue Agnostic Drug Marks Paradigm Shift In Cancer
Vitrakvi is effective against a wide variety of cancers driven by NTRK fusion. But finding the patients who will benefit will be a challenge, given there are expected to be only around 2,500 to 3,000 new cases in the US and testing for the mutation is uncommon.
Vitrakvi, Daurismo Approvals Put US FDA On Brink Of Another Record
'Cashing In' On Biobank Networking: BC Platforms Aims To Globalize Its Finnish Model
Privately-held BC Platforms is one of the networked groups leading the way in clinical genomics data management. Its CEO tells Scrip how the company's foundational start in Finland 21 years ago allowed it to create a critical mass from which it is now expanding globally in the quest to better understand the pathogenic mechanism of diseases.
Company Information
- Industry
-
Biotechnology
-
Drug Discovery Tools
- Genomics-Proteomics
- Nanotechnology, Chips, etc.
- Pharmacogenetics-Pharmacogenomics
-
Drug Discovery Tools
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
-
Research, Analytical Equipment & Supplies
- PCR & Amplification Tools
- Services
- Therapeutic Areas
- Non-Specific
- Alias(es)
- Ownership
- Public
- Headquarters
-
Worldwide
-
North America
-
USA
-
USA
-
North America
- Parent & Subsidiaries
- Illumina Inc.
- Senior Management
-
Francis deSouza, Pres. & CEO
Sam Samad, CFO
Mark Van Oene, SVP, Chief Commercial Officer
Garrett Hampton, PhD, EVP, Clinical Genomics
Omead Ostadan, EVP, Products & Ops
Mark Stapley, EVP, Strategy & Corp Dev
Mostafa Ronaghi, PhD, SVP, CTO - Contact Info
-
Illumina Inc.
Phone: (858) 202-4500
5200 Illumina Way
San Diego, CA 92122
USA
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice